Results 91 to 100 of about 30,081 (162)

A 3D co-culture model with fibroblast-restricted FAP expression for cancer therapy using [²¹²Pb]Pb-FAPI-46. [PDF]

EJNMMI Radiopharm Chem
Kristiansen SK, Dernjani N, Bruland ØS, Edin NFJ, Juzeniene A.   +4 more
europepmc   +1 more source

EZH2 inhibition via GSK-126 mitigates EndMT and atherosclerosis in diabetes: A translational epigenetic approach. [PDF]

Sci Adv
Aziz M, Sourris KC, Pinzon-Cortes JA, Block TJ, Dai A, Maxwell S, Okabe J, Calkin AC, Cooper ME, Jandeleit-Dahm KAM, Khan AW.   +10 more
europepmc   +1 more source

The evolving role of targeted radioligand therapy in small cell and non-small cell lung cancer: a systematic review. [PDF]

Explor Target Antitumor Ther
Moghrabi S, Ruzzeh S, Al-Rabi K, Abdlkadir A, Al-Jaghbeer MJ, Alzorgan N, Rasheed UA, Alqudah M, Al-Ibraheem A.   +8 more
europepmc   +1 more source

Prognostic impact of discordant lesions on [¹⁸F]FDG and [⁶⁸Ga]Ga-FAPI-04 PET/CT compared to histological FAP expression in neuroendocrine neoplasms. [PDF]

Front Nucl Med
Jedamzik T, Kosmala A, Kircher S, Heinrich M, Schlötelburg W, Buck AK, Meining A, Werner RA, Weich A, Michalski K.   +9 more
europepmc   +1 more source

Imaging of Fibroblast Activation Protein in the Microenvironment of Tumors by ¹⁸F‑Labeled Positron Emission Tomography Tracers with Increased Polarity. [PDF]

ACS Pharmacol Transl Sci
Köchel R, Wagner S, Breyholz HJ, Schäfers M, Schwegmann K, Wünsch B.   +5 more
europepmc   +1 more source

The Family Adoption Program Experience of MBBS Students in North India: A Cross-Sectional Study. [PDF]

Indian J Community Med
Mohta A, Tiwari PK, Rastogi S.
europepmc   +1 more source

Colonoscopic surveillance without prophylactic colectomy in familial adenomatous polyposis: who are the appropriate candidates? [PDF]

Clin Endosc
Lee HJ.
europepmc   +1 more source

Efficacy and Safety of Fibroblast Activation Protein Targeted Radioligand Therapy for Advanced Solid Tumour: A Systematic Review and Meta-Analysis. [PDF]

Dose Response
Zhang X, Cao J, Jiang X, Xia Y, Huang Y, Liu Q, Liu L, Xu D, Wu H, Tu W, Shi Y.   +10 more
europepmc   +1 more source

Antibody-conjugated SIS3-loaded PLGA@polydopamine nanoparticles alleviate cardiac fibrosis by modulating Smad3 signaling in myofibroblasts. [PDF]

J Nanobiotechnology
Chen C, Lu W, Pan Q, Cui C, Zhang Y, Wang H, Han J, Yuan S, Lin Z, Xie Y, Dou K, Hou J.   +11 more
europepmc   +1 more source

Simlukafusp alfa (FAP-IL2v) plus atezolizumab with or without bevacizumab in unresectable, metastatic renal cell carcinoma: a randomized, open-label phase Ib study. [PDF]

J Immunother Cancer
Perez-Gracia JL, Mellado B, Hansen AR, Alonso-Gordoa T, Gomez-Roca C, Løvendahl Eefsen R, Negrier S, Suárez C, Lee JL, Hussain A, Pedrazzoli P, Moreno V, Rodriguez-Vida A, Sosman JA, Waddell T, Bedke J, Park SH, Sznol M, Spychaj L, Andersson E, Julien-Laferriere A, Cheng WY, Watson C, Silva AP, Heichinger C, Staedler N, Sleiman N, Dejardin D, Boetsch C, Evers S, Vardar T, Ardeshir-Tandon C, Dorado Pérez J, Charo J, Keshelava N, Kraxner A, Teichgräber V, Powles T.   +37 more
europepmc   +1 more source